Home > Insider Trading > Filing (0001232524-14-000111)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1232524	Jazz Pharmaceuticals Plc	JAZZ	Pharmaceutical Preparations (2834)	981032470

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1394522	K Jeffrey Tobias	C/O Jazz Pharmaceuticals Plc Connaught House, 1 Burlington Rd, Fl. 4 Dublin 4 L2	Evp, Research & Dev And Cmo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Ordinary Shares	Disposition	2014-08-11	4,565	$133.86	42,538	No	4	F	Direct
Ordinary Shares	Acquisiton	2014-08-11	2,561	$46.83	45,099	No	4	M	Direct
Ordinary Shares	Acquisiton	2014-08-11	2,372	$59.13	47,471	No	4	M	Direct
Ordinary Shares	Disposition	2014-08-11	4,933	$135.42	42,538	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	F	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	Nonstatutory Stock Option (right to buy)	Disposition	2014-08-11	2,561	$0.00	2,561	$46.83
Ordinary Shares	Nonstatutory Stock Option (right to buy)	Disposition	2014-08-11	2,372	$0.00	2,372	$59.13

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
30,019		2022-08-08	No	4	M	Direct
17,187		2023-03-04	No	4	M	Direct

Footnotes

Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.
The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.12 to $135.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Following the reported transaction, the remaining ordinary shares subject to this option will vest with respect to 20,487 shares in equal monthly installments from September 9, 2014 to December 9, 2015 and with respect to 9,532 shares in equal monthly installments from January 9, 2016 to August 9, 2016.
Following the reported transaction, the remaining ordinary shares subject to this option are vested with respect to 2,603 shares and will vest with respect to 2,084 shares in equal monthly installments from September 5, 2014 to December 5, 2014 and with respect to 12,500 shares in equal monthly installments from January 5, 2015 to December 5, 2016.